Project List for Semester 1 AY2025/26
APROXY II
This patented technology combines DNA tags with immunoassays to deliver PCR-level sensitivity and faster results than current point-of-care and rapid tests, all within a simple 30-minute mix-and-incubate process. Designed for easy use in a compact cartridge and reader, it enables reliable point-of-care testing for conditions like heart disease, allergies, and respiratory illnesses. The team needs to find a “must-have” need for this technology and develop a business model to take this tech to market.
GREENTUBE
The innovation consists of a process, which transforms Carbon Dioxide (CO2) into carbon nanotubes (CNTs) via electrochemistry. CO2 is bubbled into an electrochemical chamber containing a molten electrolyte. As the reaction proceeds, CO2 is converted into CNTs and deposited on the surface of the electrode. At the end of the reaction, the electrode is removed from the reaction chamber, and the CNTs are harvested. There is a need to consider if this is a commercially viable method to capture carbon from the atmosphere while producing a useful by product.
MetaNose II
MetaNose is a cutting-edge breath analysis device designed to non-invasively detect and monitor metabolic conditions by measuring trace levels of volatile organic compounds (VOCs) in exhaled breath. Powered by proprietary signal processing algorithms, MetaNose delivers highly sensitive and stable readings, enabling applications such as fat-burning tracking, ketogenic diet monitoring, and early detection of diabetic ketoacidosis (DKA) and other metabolic disorders. The team will understand customer needs and design a commercially viable plan to take this innovation to market.
REBEE III
Rebee Health develops remote monitoring solutions using wearable sensors and a patient friendly mobile app, enabling remote real-time feedback, monitor progress and adjust programs remotely based on key data insights, such as range of motion, compliance, pain levels, difficulty, and patient outcome scores.
Potential areas where Rebee can be effective are chronic pain management, neurological, orthopedic, oncology, geriatric, and cardiovascular rehabilitation for patients undergoing physical rehabilitation after injury or surgery. The team must find the most financially viable market to scale up Rebee.
STRUTT
The Strutt ev¹ is a new form of smart personal transport. It’s built around an intelligent Co-Pilot technology which helps navigate everyday obstacles so one can concentrate on the things that matter. This means collisions are prevented, and when needed, the ev¹ will help steer through narrow, crowded and typically stressful environments. The team will find a “must-have” need for this technology and design a commercially viable plan to enter the market.